Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Gold and Silver rallies prompt investor to load up on Bronze
    • Satire

    Gold and Silver rallies prompt investor to load up on Bronze

    Having watched many Olympic Games over the year, investor Hugh Honey is confident that Bronze will be the next commodity to boom following recent rallies in Gold and Silver prices.  So confident is Honey, he has taken out various loans to hire storage spaces and filled them with the metal having stockpiled Bronze while it

    Read More
    Public
  • Hand sanitiser: WA Government engages Matrix for solar-powered smart dispensers
    • News

    Hand sanitiser: WA Government engages Matrix for solar-powered smart dispensers

    Even once we’re all vaccinated, the mass adoption of hand sanitiser availability is likely to stay for a while with Matrix Composites & Engineering (ASX: MCE) engaged by the West Australian Government to develop solar-powered bulk dispensers for public use.  The $1.5 million contract will see Matrix produce two prototypes for the bulk dispensers which

    Read More
    Public
  • Cosmetics distributer seeks $6m IPO to launch own brand of EZZ skincare
    • News

    Cosmetics distributer seeks $6m IPO to launch own brand of EZZ skincare

    Australian skincare company, EZZ Life Science Holdings Limited (Prospective ASX: EZZ), are the latest small cap looking to list on the exchange this month after a strong FY20 for the company. EZZ life is looking to raise $6M at an offer price of $0.50 per share, giving the company an indicative market capitalisation of $19M

    Read More
    Public
  • Pandemic focus on living better sends Healthia’s earnings skyward
    • News

    Pandemic focus on living better sends Healthia’s earnings skyward

    Vowing to look after themselves better in the wake of a pandemic, Australians are keenly focused on their personal health and wellness as evidenced by allied healthcare services provider Healthia (ASX: HLA) which is expected to report more than an 86% increase in earnings.  A market update was provided by Healthia which operates a network

    Read More
    Public
  • Paradigm eyes FDA and TGA submission as patient data confirms major joint pain reduction
    • News

    Paradigm eyes FDA and TGA submission as patient data confirms major joint pain reduction

    Clinical data trials being conducted by Paradigm Biopharmaceuticals (ASX: PAR) continue to deliver impressive patient outcomes for sufferers of chronic joint pain and osteoarthritis with 13 new patients having joined the trials and reported significantly better quality of life upon treatment with Zilosul. The most recent round of trials have been conducted in Australia under

    Read More
    Public
  • Should investors succumb to the BNPL FOMO?
    • Opinion

    Should investors succumb to the BNPL FOMO?

    As with the coronavirus, the buy now pay later (BNPL) sector was expected to have fizzled out by now. Instead, it’s stepped up another level in terms of revenue usage trends and valuations. Among investors, Fear of Missing Out (FOMO) is rife as the BNPL contagion continues to displace the role of credit cards in

    Read More
    Public
  • «
  • ‹
  • 534
  • 535
  • 536
  • 537
  • 538
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.